While CROs and healthcare have continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains a huge challenge.
So, what are companies doing to improve the situation? And what practical steps will be taken to ensure more diverse clinical trials in the future?
To find out, I spoke to a panel including three clinical trial experts in a live webinar:
- Matt Walz, CEO of Trialbee
- John Reites, CEO of THREAD
- Stuart Goldblatt, former Chief of Organisational Effectiveness at Covance and a current operational effectiveness & strategy leader.
Together, we spoke about decentralised trials, telehealth, engaging rural populations and more. To receive a downloadable PDF of all the event's major takeaways, click here.
This is only the beginning of addressing diversity in clinical trials and I'm aware of how important diverse voices are. So, CM Life Science will continue to provide podcasts, articles and webinars on this. If you’d like to get involved or know anyone who would – please get in touch. My email is Elisabeth.Edmonds@lifesci-cm.com.
For more about myself and more of my content on the clinical trial space, visit my profile page.
Alongside the growing trend of value-based searches, I wanted to delve into why candidates prioritise companies that focus on fundamental principles and ethics which resonate with them, as opposed to other more material benefits. Find out why, here.
In this episode, Jack speaks with two Co-Founders at Centivax about life as successful entrepreneurs, the journey to acquisition, challenges and learnings - and using them to become an industry-defining author. Listen now.
In this episode, Jack speaks with Twlya Tiongson Neal, Managing Director at Accenture, about commercial strategy and what this really looks like in the current life science landscape. Click to listen.
Comments.